Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856680) titled 'Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study' on Sept. 28.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Brent Kramer

Condition: Anterior Blepharitis

Intervention: Drug: NATACYN(R)

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: October 2026

Target Sample Size: 60

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07856680

Published by HT Digital Content Services with permission from ...